| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 16:10 Tx date 2025-05-29 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+11,000 vol |
11,000 | |
| Filed 2025-06-03 16:08 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-04-07 20:08 Tx date 2025-03-24 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-100,000 vol $0.03 each |
200,000 | |
| Filed 2024-02-22 09:24 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-17,142 vol |
2,858 | |
| Filed 2024-02-22 09:23 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-171 vol |
29 | |
| Filed 2023-11-08 15:33 Tx date 2023-10-30 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
| Filed 2023-11-08 15:31 Tx date 2023-10-30 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
| Filed 2023-07-21 18:26 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2023-07-21 18:25 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 20:00 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200 | ||
| Filed 2020-04-29 18:15 Tx date 2020-04-13 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,500
+50,000 vol $0.41 each |
50,000 | |
| Filed 2020-04-07 15:18 Tx date 2020-04-06 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
0 | |
| Filed 2020-04-07 15:17 Tx date 2020-04-06 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+50,000 vol |
300,000 | |
| Filed 2018-11-08 Tx date 2018-10-29 |
$
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2018-11-08 Tx date 2018-10-29 |
$
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$302,906
+59,863 vol $5.06 each |
212,787 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
5,849 | |
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
7,870 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |